A study led by a UB pediatric endocrinologist has found that a drug currently on the market for other autoimmune conditions can preserve the beta cells of children and young adults recently diagnosed with Type 1 diabetes.
Paper reflects on how coronavirus pandemic has changed food retail, and provides recommendations for research to understand the impact of the pandemic on the retail food environment and consumer behavior.
The video game version of “Sofia," which debuted this week at Buffalo's children's museum, was created by researchers in the Clinical and Translational Science Institute (CTSI) to educate childrens and their parents about clinical research.
When the COVID-19 pandemic caused the temporary shutdown of UB research laboratories last March, UB biochemist Jennifer Surtees, like many of her colleagues, couldn’t help but consider how her expertise might be applied to the novel coronavirus.
BUFFALO, N.Y. – In research led by a University at Buffalo pediatric endocrinologist, a drug called golimumab showed that it preserved beta-cell function in children and young adults with newly diagnosed Type 1 diabetes, according to findings from a Phase 2 study.
The goal of UBIB Research Day is to allow researchers who are studying ingestive/eating behavior, obesity, and related topics to become more familiar with each other’s work in order to foster collegiality and stimulate new interdisciplinary collaborations. Abstracts can be representative of a range of ingestive behavior work, including animal and human studies, from basic science to applied research.